Business NewsPR NewsWire • The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis® by the FDA

The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis® by the FDA

The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis® by the FDA

BLAINVILLE, QC, April 9, 2013 /CNW Telbec/ - Following the US approval of its morning sickness medication Diclegis by the US Food and Drug Administration (FDA), the Canadian pharmaceutical company Duchesnay Inc. is proud to announce that this approval sets the obstetric medicine...

View More : http://www.prnewswire.com/news-releases/the-canadian-pharmaceutical-company-duchesnay-inc-sets-for-international-expansi...
Releted News by prnewswire
The Venezuelan Defense Industry - Market Attractiveness and Emerging Opportunities to 2017: Market Profile
The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis® by the FDA
The Polish Defense Industry - Market Attractiveness and Emerging Opportunities to 2017: Market Profile